SOX9 and medulloblastoma: Importantly, differential expression of SOX genes (SOX4, SOX9, and SOX11) in pediatric brain tumors has been used as prognostic marker for disease progression and outcomes in ependymoma and medulloblastoma (de Bont et al., 2008).